BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20946242)

  • 1. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury.
    Nag S; Kapadia A; Stewart DJ
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):3-23. PubMed ID: 20946242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
    Nag S; Venugopalan R; Stewart DJ
    Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology and properties of brain endothelial cells.
    Nag S
    Methods Mol Biol; 2011; 686():3-47. PubMed ID: 21082365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tight junctions and loss of barrier function in pathophysiology.
    Harhaj NS; Antonetti DA
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1206-37. PubMed ID: 15109567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier/neurovascular unit in health and disease.
    Hawkins BT; Davis TP
    Pharmacol Rev; 2005 Jun; 57(2):173-85. PubMed ID: 15914466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific AHNAK expression in brain endothelial cells with barrier properties.
    Gentil BJ; Benaud C; Delphin C; Remy C; Berezowski V; Cecchelli R; Feraud O; Vittet D; Baudier J
    J Cell Physiol; 2005 May; 203(2):362-71. PubMed ID: 15493012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown.
    Yeung D; Manias JL; Stewart DJ; Nag S
    Acta Neuropathol; 2008 Jun; 115(6):635-42. PubMed ID: 18357461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of blood-brain barrier breakdown.
    Nag S
    Methods Mol Med; 2003; 89():97-119. PubMed ID: 12958415
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathology and new players in the pathogenesis of brain edema.
    Nag S; Manias JL; Stewart DJ
    Acta Neuropathol; 2009 Aug; 118(2):197-217. PubMed ID: 19404652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Changes Associated with the Protective Effects of Angiopoietin-1 During Blood-Brain Barrier Breakdown Post-Injury.
    Nag S; Manias JL; Kapadia A; Stewart DJ
    Mol Neurobiol; 2017 Aug; 54(6):4232-4242. PubMed ID: 27335031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental evaluation of blood-brain barrier permeability using colloidal gold particles as tracers in early-stage brain injury.
    Xu RX; Yi SY; Wang BY
    Chin Med J (Engl); 1991 Aug; 104(8):634-8. PubMed ID: 1655363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
    Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
    Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC.
    Alvarez JI; Teale JM
    J Neuroimmunol; 2006 Apr; 173(1-2):45-55. PubMed ID: 16406118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.
    Cardoso FL; Brites D; Brito MA
    Brain Res Rev; 2010 Sep; 64(2):328-63. PubMed ID: 20685221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches.
    Sharma HS; Johanson CE
    Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide.
    Boveri M; Kinsner A; Berezowski V; Lenfant AM; Draing C; Cecchelli R; Dehouck MP; Hartung T; Prieto P; Bal-Price A
    Neuroscience; 2006; 137(4):1193-209. PubMed ID: 16343789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.